Investors Compete To Lead Pfizer Derivative Suit
Institutional investor Amalgamated Bank is competing with an individual shareholder over who will lead a consolidated derivative lawsuit alleging that Pfizer Inc.'s executives harmed the company by promoting prescription drugs for...To view the full article, register now.
Already a subscriber? Click here to view full article